Bio
Rumiana Tenchov is an information scientist at CAS. She earned her Ph.D. and D.Sc. degrees in biophysics from the Bulgarian Academy of Sciences. Prior to joining CAS, she was a research faculty member at the Department of Molecular Biosciences of the Northwestern University.
新興の科学分野
CAS Insights Report: New techniques in assisted reproductive technology
Breakthroughs in assisted reproductive technology could overcome infertility challenges.
創薬
Nano-sized drug delivery systems can treat cancer, HIV, and more
Nanoscale drug delivery systems can improve treatment for cancer, autoimmune diseases, HIV, and other conditions
創薬
希少疾患とオーファン疾患：併用療法で治療できるのか？
薬剤リポジショニング、細胞療法、遺伝子療法を含む併用療法が、いかに希少疾患の治療改善につながっているか。
新興の科学分野
Decoding neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's
Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
バイオテクノロジー
Can we use existing drugs to cure Parkinson’s disease?
Parkinson's disease can be distressing for families, so scientists are working hard to find potential treatments by repurposing drugs and more.
創薬
Ending Alzheimer's: Emerging trends in biomarkers, gene therapy, and more
Biomarkers, personalized medicine and gene therapies are fueling research breakthroughs. Discover new treatments targeting genetics and protein buildup to manage this devastating disease.
創薬
Can we cure Huntington's? Research trends in PolyQ and rare diseases
While no cure exists for PolyQ diseases like Huntington's, new breakthroughs, therapies, and research could change that.
新興の科学分野
Biomarkers: The key to earlier cancer detection and patient outcomes
CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
バイオテクノロジー
How biomarkers unlock faster cancer detection, improving outcomes
As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
創薬
抗体薬物複合体 - その広がる可能性
2018年以降、がんとの闘いにおける可能性から、抗体薬物複合体に関する研究への関心が飛躍的に増加しています。
新興の科学分野
Aging reimagined: Exploring the potential of anti-aging treatment strategies
Discover the latest in anti-aging treatment strategies to promote health and longevity, including stem cell therapies, hyaluronic acid, senolytics, gene therapy, and more.
新興の科学分野
PEG化脂質ナノ粒子の完全ガイド
PEGの免疫原性は、薬物送達のためのPEG化脂質ナノ粒子の安全性と有効性に影響します。これらのポリマーを応用する際の課題を克服するための研究が盛んに行われています。
新興の科学分野
敵ではなく味方 - 健康のために腸内マイクロバイオームを利用する
腸内マイクロバイオームとは、私たちの消化管に生息する数兆個の細菌からなる複雑なエコシステムで、免疫力や精神状態の改善、治療の選択肢など、健康上の利点があります
バイオテクノロジー
The evolving exosome: from small player to rising star
A historical overview of the discovery of exosomes, key milestones in their rise, and why they will revolutionize the diagnostic and drug delivery fields in the future.
安全性
硝酸アンモニウム：より良い明日のために、今日をより安全に
硝酸アンモニウムは、何十億人もの食料を供給する力を持つ一方で、不適切に貯蔵されれば、爆弾のように危険なものでもあります。この肥料の安全性を高めるには、どうしたらいいのでしょうか。そこで、最新の科学情報や、より安全な代替物、そして安全な貯蔵と輸送のにおけるベストプラクティスについて説明します。
創薬
COVID-19以外にも広がるナノテクノロジーによる治療の可能性
脂質ナノ粒子を探求する：その起源からCOVIDワクチン、そして将来の応用まで。各種論文とマイルストーンにおける新たなトレンドを見てみましょう。ワクチン、薬物送達、農芸化学、化粧品、食品科学などの非治療分野における将来の応用を探ります。これらの粒子がどのように形成されているかをご覧ください。
創薬
With COVID BA.5 and BA.2.75 variants, are masks back in?
The COVID pandemic revealed deficiencies in mask development and production. Innovation will be crucial in slowing the spread of new variants of the virus.
創薬
Are intrinsically disordered proteins the key to treating COVID-19?
Learn about the important functions of intrinsically disordered proteins and the key role they play in COVID-19 therapy.
新興の科学分野
腸内マイクロバイオームと、うつ病や不安症などとの関係
Gut microbiota, gut flora, or microbiome are the microorganisms that live in the digestive tracts of humans and other animals. While some bacteria are associated with disease, others are particularly important for many aspects of health and mental health.
バイオテクノロジー
Lipid Nanoparticles – Key Players in Cancer Treatment
Learn more about the applications of lipid nanoparticles in cancer therapy, their therapeutic benefits, and their future within nanomedicine.
新興の科学分野
Tackling the global vaccine distribution challenge
Newly developed microfluidic fabrication technology addresses the clinical need for scalable, precise, and reproducible solutions for vaccine production.
持続可能性
プラスチックを「食べる」スーパー酵素はプラスチック問題を解決できるか
通常なら数百年かかるところを、微生物の酵素がいかにプラスチックを分解するかに関する研究の概要です。